Journals / Adnan Menderes Üniversitesi Tıp Fakültesi Dergisi / 2011 / Cilt: 12 - Sayı: 3

Miller-Fisher syndrome: A case report

Miller- Fısher sendromu: Bir olgu sunumu

Pages
37–40
Publication Date
2022-10-10
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The aim of the case is presented here to remind this very uncommon antity.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Miller-Fisher syndrome is characterized by gait ataxia, external ophtalmoplegia and areflexia and thought as an uncommon variant of Guillain Barre syndrome.
📊
Key Findings & Data:Miller-Fisher syndrome is observed in about 5-8% of all Guillain Barre syndrome cases.
💡
Conclusion & Impact:The aim of the case is presented here to remind this very uncommon antity.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Miller-Fisher syndrome is characterized by gait ataxia, external ophtalmoplegia and areflexia and thought as an uncommon variant of Guillain Barre syndrome. Miller-Fisher syndrome is observed in about 5-8% of all Guillain Barre syndrome cases. Acute onset of external ophthalmoplegia is a cardinal feature of Miller-Fisher syndrome. Miller-Fisher syndrome can be distinguished from Guillain Barre syndrome by a few clinical features. Because of the laboratory findings are not spesific for Miller-Fisher syndrome, the diagnosis is made only with suspicion of the disease. Miller-Fisher syndrome was diagnosed at a five years old girl with gait ataxia, ophthalmoplegia, hyporeflexia, cerebrospinal fluid and electromyographic findings. Intravenous immunoglobulin 1g/kg/dose was used for two days. The aim of the case is presented here to remind this very uncommon antity.

Özet

Miller-Fisher sendromu ataksi, oftalmopleji ve arefleksi ile karakterizedir ve Guillain Barre sendromunun bir varyantı olduğu düşünülmektedir. Miller-Fisher sendromu tüm Guillain Barre sendromlu olguların %5-8'ini oluşturur. Ani başlangıçlı eksternal oftalmopleji Miller-Fisher sendromunun kardinal bulgusudur. Miller-Fisher sendromu Guillain Barre sendromundan yalnızca birkaç klinik özellikle ayırt edilebilmekte, laboratuvar bulguları özgün olmadığı için tanı ancak hastalıktan şüphelenildiği durumda konulabilmektedir. Yürüme ataksisi, oftalmopleji ve derin tendon reflekslerinde azalma saptanan beş yaşındaki kız olguda beyin omurilik sıvısında albuminositolojik disosiyasyon, elektromiyografide alt ekstremite distallerinde mikst tip polinöropati bulgularıyla birlikte Miller-Fisher sendromu tanısı konuldu. İntravenöz immunoglobulin 1 g/kg/doz iki gün kullanıldı. Oldukça nadir görülen bir antite olması nedeniyle hatırlatmak amacıyla sunuldu.

🔖

Cite This Article

ÖNDER, Z. S., ÜNALP, A., GÜLEZ, P., HIZARCIOĞLU, M. (2022). Miller-Fisher syndrome: A case report. Adnan Menderes Üniversitesi Tıp Fakültesi Dergisi, Cilt: 12 - Sayı: 3, 37–40. https://ajindex.com/articles/428902

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (17)

  1. Sladky JT, Ashwal S. Inflammatory neuropathies. In: Swaiman KF, Ashwal S, Ferriero DM, editors. Pediatric neurology. Principles and practice. 4th ed. Elsevier, Philadelphia, 2006: 1923
  2. Bushra JS. Miller-Fisher syndrome: an uncommon acute neuropathy. J Emerg Med 2000;18;427-30
  3. Van der Meche FG, van Doorn PA, Meulstee J, Jennekens FG. Diagnostic and classification criteria for the Guillain Barre syndrome. Eur Neurol 2001;45:133-9
  4. Ito M, Kuwabara S, Odaka M, et al. Bickerstaff's brainstem encephalitis and Fisher syndrome from a continuous spectrum: clinical analysis of 581 cases. J Neurol 2008;255:674-82
  5. Sarnat HB. Guillain Barre Syndrome. In: Kliegman RM, Behrman RE, Jenson HB, Stanton BF, editors. Nelson textbook of pediatrics. 18th ed. WB Saunders, Philadelphia, 2007: 2565-6. 6) van der Meche FG, van Doorn PA. Guillain Barre syndrome. Curr Treat Options Neurol 2000;2:507-16
  6. Yuan CL, Wang YJ, Tsai CP. Miller-Fisher syndrome: A hospital-based retrospective study. Eur Neurol 2000;2:507-16
  7. Snyder LA, Rismondo V, Miller NR. The Fisher variant of Guillain-Barre syndrome (Fisher syndrome). J Neuroophtalmol 2009;29:312-324
  8. Fisher M. An unusual variant of acute idiopathic polyneuritis (syndrome of ophtalmoplegia, ataxia and areflexia). N Engl J Med 1956;255:57-65
  9. Bushra JS. Miller Fisher syndrome: an uncommon acute neuropathy. J Emerg Med 2000;18:427-30
  10. Yuan CL, Wang YJ, Tsai CP. Miller Fisher syndrome: a hospital-based retrospective study. Eur Neurol 2000;44:79-85
  11. Lyu RK, Tang LM, Cheng SY, et al. Guillain Barre syndrome in Taiwan: a clinical study of 167 patients. J Neurol Neurosurg Psychiatry 1997;63:494-500
  12. Mori M, Kuwabara S, Fukutake T, et al. Clinical features and prognosis of Miller-Fisher Syndrome. Neurology 2001; 56:1104-6
  13. Berlit P, Rakicky J. The Miller Fisher syndrome; Review of literature. J Clin Neuroophtalmol 1992;12:57-63
  14. Yuki N, Odaka M, Hirata K. Acute ophthalmoparesis (without ataxia) associated with anti-GQ1b IgG antibody: clinical features. Ophthalmology 2001;108:196-200
  15. Paparounas K. Anti-GQ1b ganglioside antibody in peripheral nervous system disorders: pathophysiologic role and clinical relevance. Arch Neurol 2004;61:1013-6
  16. Chiba A, Kusunoki S, Shimizu T, Kanazawa I. Serum IgG antibody to gangliozide GQ1b is a possible marker of Miller Fisher syndrome. Ann Neurol 1992;31:677-9
  17. Chiba A, Kusunoki S, Obata H, Machinami R, Kanazawa I. Serum anti-GQ1b IgG antibody is assoc